Paid Clinical Trials Fargo

Discover 36 paid clinical trials in Fargo, North Dakota. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter

Filter results

Results: 36

Observational StudyAlcohol Related Impairment and Reinforcement: Pre to Post Roux en Y Gastric Bypass Surgery

Recruiting

Sponsor:

Neuropsychiatric Research Institute, Fargo, North Dakota

Location:

Fargo ND

Code:

NCT02370732

Conditions

Bariatric Surgery Candidate

Eligibility Criteria

Sex: All

Age: 21 - 65

Healthy Volunteers: Accepted

Interventions

Alcohol

Biobank RegistryTEMPUS ARIES: A Biobank Registry Platform Study in Oncology

Recruiting

Sponsor:

Tempus AI

Location:

Fargo ND, Rolling Meadows IL, Peoria IL, Hinsdale ILshow 20 more

Code:

NCT06207032

Conditions

Cancer

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Pembrolizumab & Sacituzumab TirxumotecanA Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)

Recruiting

PHASE3

Sponsor:

Merck Sharp & Dohme LLC

Location:

Fargo ND, Minneapolis MN, Sioux Falls SD, Naperville ILshow 22 more

Code:

NCT06312137

Conditions

Non Small Cell Lung Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Sacituzumab tirumotecan

Pembrolizumab

Cisplatin

Pemetrexed

Gemcitabine

PembrolizumabKEYMAKER-U01 Substudy 01A: Efficacy and Safety Study of Pembrolizumab (MK-3475) With or Without Chemotherapy When Used With Investigational Agents in Treatment-naïve Participants With Stage IV Non-small Cell Lung Cancer (NSCLC) (MK-3475-01A/KEYMAKER-U01A)

Recruiting

PHASE1

PHASE2

Sponsor:

Merck Sharp & Dohme LLC

Location:

Fargo ND, Sioux Falls SD, Omaha NE, Cleveland OHshow 13 more

Code:

NCT04165070

Conditions

Carcinoma, Non-Small-Cell Lung

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Pembrolizumab

Carboplatin

Paclitaxel

Pemetrexed

Vibostolimab

RavulizumabARTEMIS: Ravulizumab to Protect Patients With CKD From CSA-AKI and MAKE

Recruiting

PHASE3

Sponsor:

Alexion Pharmaceuticals, Inc.

Location:

Fargo ND, Winnipeg, Wisconsin Rapids WI, Lincoln NEshow 43 more

Code:

NCT05746559

Conditions

Chronic Kidney Disease

CKD

Cardiac Disease

Cardiopulmonary Bypass

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Placebo

Ravulizumab

SonelokimabStudy to Evaluate the Efficacy and Safety of Subcutaneous Sonelokimab Compared with Placebo in Adult Participants with Moderate to Severe Hidradenitis Suppurativa

Recruiting

PHASE3

Sponsor:

MoonLake Immunotherapeutics AG

Location:

Fargo ND, New Brighton MN, Omaha NE, Skokie ILshow 32 more

Code:

NCT06411379

Conditions

Hidradenitis Suppurativa

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Sonelokimab

Placebo

DupilumabEvaluation of Dupilumab in Patients With Atopic Keratoconjunctivitis (AKC)

Recruiting

PHASE2

Sponsor:

Andover Eye Associates

Location:

Fargo ND, Kansas City MO, Littleton CO, Town And Country MOshow 16 more

Code:

NCT04296864

Conditions

Atopic Keratoconjunctivitis

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Dupilumab

LunsekimigA Study to Investigate the Efficacy and Safety of Subcutaneous Lunsekimig (SAR443765) Compared With Placebo in Adult Participants With Moderate-to-severe Atopic Dermatitis

Recruiting

PHASE2

Sponsor:

Sanofi

Location:

Fargo ND, Rapid City SD, Saint Joseph MO, Plainfield INshow 8 more

Code:

NCT06790121

Conditions

Dermatitis Atopic

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Lunsekimig

Placebo

DupilumabEfficacy and Safety of Subcutaneous Dupilumab for the Treatment of Adult Participants With Chronic Pruritus of Unknown Origin (CPUO) (LIBERTY-CPUO-CHIC)

Recruiting

PHASE3

Sponsor:

Sanofi

Location:

Fargo ND, Bellevue NE, Indianapolis IN, Verdunshow 19 more

Code:

NCT05263206

Conditions

Pruritus

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Dupilumab

Placebo

Fexofenadine (loratadine if not available)

Moisturizer

LF111 vs. Non-hormonalLF111 or Drospirenone Chew vs Non-hormonal Contraceptive Methods on Bone Mineral Density in Adolescent and Adult Women

Recruiting

Sponsor:

Insud Pharma

Location:

Fargo ND, Norfolk NE, Denver CO, Boise IDshow 15 more

Code:

NCT05303636

Conditions

Change in Bone Mineral Density

Bone Loss

Eligibility Criteria

Sex: Female

Age: 14 - 45

Healthy Volunteers: Accepted

Interventions

LF111 (drospirenone 4 mg oral tablet) or drospirenone (DRSP) 3.5 mg chewable tablet